ABCL - AbCellera Biologics GAAP EPS of $0.50 misses by $0.09 revenue of $485.42M misses by $32.31M February, 21 2023 04:10 PM AbCellera Biologics Inc. AbCellera Biologics press release ( NASDAQ: ABCL ): FY GAAP EPS of $0.50 misses by $0.09 . Revenue of $485.42M (+29.4% Y/Y) misses by $32.31M . For further details see: AbCellera Biologics GAAP EPS of $0.50 misses by $0.09, revenue of $485.42M misses by $32.31M